GPT-Rosalind (OpenAI) vs Perplexity Comet
Which one should you pick? Here's the full breakdown.
GPT-Rosalind (OpenAI)
OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)
Perplexity Comet
Perplexity's agentic AI browser -- FREE on all platforms as of 2026-03-18 (previously $200/mo Max-only). iOS, Android, Windows, Mac. Browses the web, executes multi-step tasks, and summarizes pages in-line. Comet Plus ($5/mo) adds premium publisher content
| Category | GPT-Rosalind (OpenAI) | Perplexity Comet |
|---|---|---|
| Ease of Use | 3.0 | 8.0 |
| Output Quality | 9.0 | 8.0 |
| Value | 7.0 | 9.5 |
| Features | 8.0 | 8.0 |
| Overall | 6.8 | 8.4 |
Pricing Comparison
| Feature | GPT-Rosalind (OpenAI) | Perplexity Comet |
|---|---|---|
| Free Tier | No | Yes |
| Starting Price | Invite only | $0 |
Which Should You Pick?
Pick GPT-Rosalind (OpenAI) if...
- ✓Higher output quality (9 vs 8)
Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.
Visit GPT-Rosalind (OpenAI)Pick Perplexity Comet if...
- ✓Easier to use (8 vs 3)
- ✓Better value for money (9.5/10)
- ✓Has a free tier
Users who already use Perplexity for search and want an agent browser that can complete multi-step tasks (booking, research, shopping, document summarization) across tabs. Also a strong introduction to the AI-browser category for anyone curious but unwilling to pay $200/mo for a preview -- the 2026-03-18 free rollout makes evaluation risk-free.
Visit Perplexity CometOur Verdict
Perplexity Comet is the clear winner here with 8.4/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but Perplexity Comet outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.